Hyaluronan binding identifies a functionally distinct alveolar macrophage-like population in bone marrow-derived dendritic cell cultures

Journal of Immunology

Volumn 195, Issue 2, 2015, Pages 632-642

  Poon, Grace F T ^a,b   Dong, Yifei ^a   Marshall, Kelsey C ^a   Arif, Arif ^a   Deeg, Christoph M ^a   Dosanjh, Manisha ^a   Johnson, Pauline ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; CCR5 PROTEIN, MOUSE; CCR7 PROTEIN, MOUSE; CD44 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BONE MARROW DERIVED DENDRITIC CELL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; IN VITRO STUDY; LIGAND BINDING; LUNG ALVEOLUS MACROPHAGE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; DEFICIENCY; DENDRITIC CELL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; PRIMARY CELL CULTURE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD44; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DENDRITIC CELLS; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HYALURONIC ACID; LIPOPOLYSACCHARIDES; LUNG; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRIMARY CELL CULTURE; RECEPTORS, CCR5; RECEPTORS, CCR7; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936803461     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402506     Document Type: Article

References (53)

1. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
2. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31: 563-604.
3. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of mac-rophage activation. Nat. Rev. Immunol. 8: 958-969.
4. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10: 427-439.
5. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
6. Hashimoto, D., J. Miller, and M. Merad. 2011. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35: 323-335.
7. Geissmann, F., S. Gordon, D. A. Hume, A. M. Mowat, and G. J. Randolph. 2010. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10: 453-460.
8. Hume, D. A., N. Mabbott, S. Raza, and T. C. Freeman. 2013. Can DCs be distinguished from macrophages by molecular signatures? Nat. Immunol. 14: 187-189.
9. Randolph, G., and M. Merad. 2013. Reply to: "Can DCs be distinguished from macrophages by molecular signatures?". Nat. Immunol. 14: 189-190.
10. Ruffell, B., G. F. Poon, S. S. Lee, K. L. Brown, S. L. Tjew, J. Cooper, and P. Johnson. 2011. Differential use of chondroitin sulfate to regulate hyaluronan binding by receptor CD44 in Inflammatory and Interleukin 4-activated Macro-phages. J. Biol. Chem. 286: 19179-19190.
11. Hussell, T., and T. J. Bell. 2014. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14: 81-93.
12. Miller, J. C., B. D. Brown, T. Shay, E. L. Gautier, V. Jojic, A. Cohain, G. Pandey, M. Leboeuf, K. G. Elpek, J. Helft, et al; Immunological Genome Consortium. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13: 888-899.
13. Vermaelen, K., and R. Pauwels. 2004. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry A 61: 170-177.
14. Gautier, E. L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft, A. Chow, K. G. Elpek, S. Gordonov, et al; Immunological Genome Consortium. 2012. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13: 1118-1128.
15. Tamoutounour, S., S. Henri, H. Lelouard, B. de Bovis, C. de Haar, C. J. van der Woude, A. M. Woltman, Y. Reyal, D. Bonnet, D. Sichien, et al. 2012. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur. J. Immunol. 42: 3150-3166.
16. Fleetwood, A. J., T. Lawrence, J. A. Hamilton, and A. D. Cook. 2007. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178: 5245-5252.
17. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
18. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
19. Brasel, K., H. J. McKenna, K. Charrier, P. J. Morrissey, D. E. Williams, and S. D. Lyman. 1997. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 90: 3781-3788.
20. Lacey, D. C., A. Achuthan, A. J. Fleetwood, H. Dinh, J. Roiniotis, G. M. Scholz, M. W. Chang, S. K. Beckman, A. D. Cook, and J. A. Hamilton. 2012. Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188: 5752-5765.
21. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
22. Naik, S. H., P. Sathe, H.-Y. Park, D. Metcalf, A. I. Proietto, A. Dakic, S. Carotta, M. O'Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8: 1217-1226.
23. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7: 19-30.
24. Xu, Y., Y. Zhan, A. M. Lew, S. H. Naik, and M. H. Kershaw. 2007. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179: 7577-7584.
25. Levesque, M. C., and B. F. Haynes. 1997. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J. Immunol. 159: 6184-6194.
26. Fraser, J. R., T. C. Laurent, and U. B. Laurent. 1997. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242: 27-33.
27. Jiang, D., J. Liang, and P. W. Noble. 2007. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23: 435-461.
28. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Puré, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.
29. Ruffell, B., and P. Johnson. 2009. The regulation and function of hyaluronan binding by CD44 in the immune system. Glycoforum: Science of hyaluronan today. Available at: http://www.glycoforum.gr.jp/science/hyaluronan/HA32/HA32E.html.
30. Johnson, P., and B. Ruffell. 2009. CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy Drug Targets 8: 208-220.
31. Levesque, M. C., and B. F. Haynes. 1999. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell. Immunol. 193: 209-218.
32. Termeer, C. C., J. Hennies, U. Voith, T. Ahrens, J. M. Weiss, P. Prehm, and J. C. Simon. 2000. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165: 1863-1870.
33. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of Hya-luronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195: 99-111.
34. Mummert, M. E., D. Mummert, D. Edelbaum, F. Hui, H. Matsue, and A. Takashima. 2002. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169: 4322-4331.
35. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90: 2217-2233.
36. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183: 891-899.
37. de Belder, A. N., and K. O. Wik. 1975. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res. 44: 251-257.
38. Liang, J., D. Jiang, J. Griffith, S. Yu, J. Fan, X. Zhao, R. Bucala, and P. W. Noble. 2007. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J. Immunol. 178: 2469-2475.
39. Bachmann, M. F., M. Kopf, and B. J. Marsland. 2006. Chemokines: more than just road signs. Nat. Rev. Immunol. 6: 159-164.
40. Kato, M., T. K. Neil, D. B. Fearnley, A. D. McLellan, S. Vuckovic, and D. N. Hart. 2000. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol. 12: 1511-1519.
41. Guth, A. M., W. J. Janssen, C. M. Bosio, E. C. Crouch, P. M. Henson, and S. W. Dow. 2009. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L936-L946.
42. Paine, R., III, S. B. Morris, H. Jin, S. E. Wilcoxen, S. M. Phare, B. B. Moore, M. J. Coffey, and G. B. Toews. 2001. Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L1210-L1218.
43. Steinman, R. M., and M. D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75: 5132-5136.
44. Stanley, E., G. J. Lieschke, D. Grail, D. Metcalf, G. Hodgson, J. A. Gall, D. W. Maher, J. Cebon, V. Sinickas, and A. R. Dunn. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91: 5592-5596.
45. Guilliams, M., I. De Kleer, S. Henri, S. Post, L. Vanhoutte, S. De Prijck, K. Deswarte, B. Malissen, H. Hammad, and B. N. Lambrecht. 2013. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210: 1977-1992.
46. Cheng, G., S. Swaidani, M. Sharma, M. E. Lauer, V. C. Hascall, and M. A. Aronica. 2011. Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol. 30: 126-134.
47. Jakubzick, C., F. Tacke, J. Llodra, N. van Rooijen, and G. J. Randolph. 2006. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 176: 3578-3584.
48. Sathe, P., D. Metcalf, D. Vremec, S. H. Naik, W. Y. Langdon, N. D. Huntington, L. Wu, and K. Shortman. 2014. Lymphoid tissue and plasmacytoid dendritic cells and macrophages do not share a common macrophage-dendritic cell-restricted progenitor. Immunity 41: 104-115.
49. Auffray, C., D. K. Fogg, E. Narni-Mancinelli, B. Senechal, C. Trouillet, N. Saederup, J. Leemput, K. Bigot, L. Campisi, M. Abitbol, et al. 2009. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 206: 595-606.
50. Culty, M., H. A. Nguyen, and C. B. Underhill. 1992. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116: 1055-1062.
51. Fejer, G., M. D. Wegner, I. Györy, I. Cohen, P. Engelhard, E. Voronov, T. Manke, Z. Ruzsics, L. Dölken, O. Prazeres da Costa, et al. 2013. Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions. Proc. Natl. Acad. Sci. USA 110: E2191-E2198.
52. Goncharova, V., N. Serobyan, S. Iizuka, I. Schraufstatter, A. de Ridder, T. Povaliy, V. Wacker, N. Itano, K. Kimata, I. A. Orlovskaja, et al. 2012. Hya-luronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis. J. Biol. Chem. 287: 25419-25433.
53. Nilsson, S. K., D. N. Haylock, H. M. Johnston, T. Occhiodoro, T. J. Brown, and P. J. Simmons. 2003. Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood 101: 856-862.